Platelet distribution width and the extent of coronary artery disease: results from a large prospective study

Giuseppe De Luca1, Luca Venegoni, Sergio Iorio

  • 1Division of Cardiology, Azienda Ospedaliera-Universitaria Maggiore della Carità, Eastern Piedmont University, Novara, Italy. giuseppe.deluca@maggioreosp.novara.it

Platelets
|September 30, 2010
PubMed

Insights

Platelet distribution width (PDW) variability in platelet size was investigated for its association with coronary artery disease (CAD) extent. This study found no significant relationship between PDW and CAD or carotid intima-media thickness, indicating PDW is not a CAD risk factor.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Diagnostic Markers

Background:

  • Large platelets, indicated by Platelet Distribution Width (PDW), are postulated as markers of platelet activation and potential indicators of Coronary Artery Disease (CAD) extent.
  • Existing research lacks data on the association between PDW and CAD.

Purpose of the Study:

  • To investigate the association between Platelet Distribution Width (PDW) and the extent of Coronary Artery Disease (CAD).
  • To explore the relationship between PDW and Carotid Intima-Media Thickness (IMT).

Main Methods:

  • PDW was measured in 1882 patients undergoing coronary angiography.
  • Significant CAD was defined as stenosis >50% in at least one coronary vessel.
  • Carotid Intima-Media Thickness (IMT) was measured in 359 patients.

Main Results:

  • PDW was not associated with the prevalence of CAD (OR [95% CI] = 0.91 [0.81–1.04], p = 0.16; adjusted OR [95% CI] = 0.96 [0.82–1.12], p = 0.56).
  • No relationship was observed between PDW and Carotid Intima-Media Thickness (IMT) (Mean IMT: r = 0.04; p = 0.46; Maximal IMT: r = 0.036, p = 0.49).
  • Higher PDW was associated with older age, higher weight and waist circumference, diabetes, specific heart conditions, and diuretic use.

Conclusions:

  • Platelet Distribution Width (PDW) is not related to the extent of Coronary Artery Disease (CAD).
  • PDW is not associated with Carotid Intima-Media Thickness (IMT).
  • PDW cannot be considered a risk factor for CAD.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...